JOHANNESBURG – Two sons of Dis-Chem founder Ivan Saltzman have received over R3.4 billion each in shares following a family restructuring of ownership in the pharmaceutical retail group.
On Friday, 20 June 2025, Dis-Chem announced that Saltzman restructured his shareholding held through Ivlyn Local Investment Holdings, resulting in the transfer of 217 million shares to his sons Dan and Mark Saltzman.
The transaction is valued at R6.8 billion, based on Dis-Chem’s closing share price on 19 June. Dan and Mark now each hold a 12.62% beneficial interest in the company.
Ivlyn Local Investment Holdings previously controlled 29.31% of Dis-Chem’s issued shares but now holds just 4.06%. All shares transferred remain within the Saltzman family, preserving their overall influence in the business.
Saul Saltzman, Ivan’s other son, serves as an executive director at Dis-Chem.
In February 2024, the Saltzman family had already reduced their stake when Ivan sold shares worth R1.43 billion to Coronation Asset Management, and Saul sold R88 million worth. That earlier transaction saw Ivlyn’s holding drop from 35.12% to 29.31%. Coronation now holds 29.83% of the company.
Dis-Chem, founded in 1978 by Ivan and Lynette Saltzman, operates 285 retail pharmacy stores and 45 Baby City outlets across South Africa. The company also owns CJ Distribution, which services its retail network from multiple warehouses nationwide.
For the year ending 28 February 2025, the group recorded an 8% rise in revenue, reaching R39.2 billion.
Discussion about this post